⚠ Insurance Gets Priced Like InsuranceHigh threat
Marvell Technology (MRVL) — threat to the moat
A second source exists to make the first one negotiable, and gets quoted accordingly.
The second-source argument is sound and it is why Marvell has a business here: no buyer spending tens of billions wants one supplier holding the roadmap. But the logic that creates the position also caps what the position earns.
A second source exists partly to discipline the first source's price. That is its job. Buyers keep one to make the other negotiable, and a supplier held for that purpose is quoted against the incumbent rather than against the value of the silicon. The share numbers make the hierarchy plain — Broadcom holds roughly 70% of custom-accelerator design share against Marvell's estimated 20-25%1 — and in a market where the leader has three times the volume, the leader also has the better cost position to defend a price war with.
There is a subtler version of the same problem. Insurance is bought in proportion to fear. A hyperscaler anxious about supply keeps a well-funded second source; one whose primary partner is executing well lets the second wither to a token program that never ramps.
The test is margin, not revenue. Marvell's non-GAAP operating margin reached 35.3% in fiscal 2026. If custom silicon grows while that margin erodes, the second-source position is being paid for out of Marvell's own economics.
- Third-party estimateBroadcom holds roughly 70% of custom-accelerator design share against Marvell's estimated 20-25%.Custom-silicon design-share estimates — Broadcom approximately 70% of custom AI accelerator design share against Marvell's estimated 20-25%; Broadcom serves Google's TPU, Meta's accelerator program and OpenAI's custom silicon — 2026 · publ. 2026 · source ↗